Bonnie Gillis

Articles

Vorinostat Added to Standard Chemotherapy Reduced the Incidence of Acute GVHD

December 10, 2012

Vorinostat added to standard chemotherapy before, during, and after hematopoietic stem cell transplantation reduced the cumulative incidence of graft-versus-host disease in a phase I/II trial reported at the 54th Annual Meeting of the American Society of Hematology.

Encouraging Phase II Data for All-Oral First-Line Regimen in Newly Diagnosed Multiple Myeloma

December 09, 2012

An investigational, weekly, oral proteosome inhibitor called MLN9708 achieved excellent response rates when combined with lenalidomide and dexamethasone as up-front treatment of newly diagnosed patients with multiple myeloma, according to results of a phase II trial presented at the 54th Annual Meeting of the American Society of Hematology.

Preliminary Evidence Suggests Ibrutinib Is a Home-Run for CLL

December 09, 2012

Ibrutinib, an investigational Bruton's tyrosine kinase inhibitor, achieved excellent results in clinical trials of patients with chronic lymphocytic leukemia (CLL) presented at the 54th Annual Meeting of the American Society of Hematology.